Maven Securities’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-35,200
Closed -$1.82M 1200
2022
Q3
$1.82M Buy
+35,200
New +$1.45M 0.03% 343

Other funds holding CCXI

Maven Securities's CCXI Position: Q4 2022 in Review

Maven Securities sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 4,000 shares — an estimated $207K sold.

Maven Securities first reported a position in CCXI in Q4 2021 and held it in 3 quarters. The position peaked at $2.32M in Q4 2021. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Maven Securities reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Maven Securities sold 4,000 ChemoCentryx, Inc. shares in Q4 2022, an estimated $207K.
  • Maven Securities first reported a position in ChemoCentryx, Inc. in Q4 2021 and held it in 3 quarters.
  • Maven Securities's ChemoCentryx, Inc. position peaked at $2.32M in Q4 2021.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Maven Securities's 13F filing for Q4 2022, filed 14 Feb 2023.